{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-PRIME/4552",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# JCR Pharmaceuticals Co.,Ltd. (Prime Market: 4552) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is JCR Pharmaceuticals Co.,Ltd., listed on the Prime Market under ticker 4552. Its LEI is 353800IMIU9CQ1DGOS14 and its ISIN is not on the record (GLEIF maps no ISIN to this LEI). Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 13 filings in the window 2025-11-06 to 2026-11-06, across 5 filing days, of which 2 are ad hoc, 9 are regulatory filings and 2 are results. The median gap between filing days is 71.0 days. The latest filing is dated 2026-07-29 and is a regulatory filing, 100 days before the record date 2026-11-06. The Prime Market median is 10 filings, a 29.0-day median cadence gap and 70.0 days median latency across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a 49.5-day median cadence gap and 85.0 days median latency across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 有限責任監査法人 トーマツ, with its location not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nThe issuer's own investor-relations page names 9 research houses: SBI SECURITIES Co., Ltd., Jefferies (Japan) Limited, Citigroup Global Markets Japan Inc., Daiwa Securities Co. Ltd., Nomura Securities Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Morgan Stanley, and MUFG Securities Co., Ltd.\n\n## Open research\n\nNo openly published research notes were found for the issuer.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record began on no recorded date.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/353800IMIU9CQ1DGOS14 (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4552 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YF19 (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/ (coverage)\n- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4552 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YF19",
    "state": "sourced",
    "value": "有限責任監査法人 トーマツ"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-PRIME/4552",
  "coverage": {
   "count": 9,
   "houses": [
    {
     "analyst": "Ryuta Kawamura",
     "house": "SBI SECURITIES Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Miyabi Yamakita",
     "house": "Jefferies (Japan) Limited",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Hidemaru Yamaguchi",
     "house": "Citigroup Global Markets Japan Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Kazuaki Hashiguchi",
     "house": "Daiwa Securities Co. Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Miho Kawamura",
     "house": "Nomura Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Yuriko Ishida",
     "house": "Mizuho Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Shinichiro Muraoka",
     "house": "Morgan Stanley MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "house": "Morgan Stanley",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Shinichiro Muraoka",
     "house": "MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/",
     "result": "read: 9 of 15 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1557,
     "median_cadence_gap_days": 29,
     "median_filings": 10,
     "median_latency_days": 70,
     "name": "Prime Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 2,
    "regulatory_filing": 9,
    "results": 2
   },
   "cadence_median_gap_days": 71,
   "filing_days": 5,
   "filings": 13,
   "latency_days": 100,
   "latest": [
    {
     "category": "135",
     "date": "2026-07-29",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YSXN",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "訂正有価証券報告書 (amended annual report)",
     "date": "2026-07-29",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YSOS",
     "title": "訂正有価証券報告書－第51期(2025/04/01－2026/03/31)",
     "type": "regulatory_filing"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-06-25",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YK42",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "135",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YIE3",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "135",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YICT",
     "title": "確認書",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-07-29",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4552",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Prime Market"
   },
   "isin": {
    "market": "JP",
    "reason": "GLEIF maps no ISIN to this LEI",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF registeredAs = EDINET corporate number (RA000412; GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/353800IMIU9CQ1DGOS14",
    "state": "sourced",
    "value": "353800IMIU9CQ1DGOS14"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "JCR Pharmaceuticals Co.,Ltd."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4552"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:c5b6f18c48929664e7a6ec9dc267de2a092d7884d969ba7d49e766f3c55af1b9",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope and the subject's record carries no instrument class to place within it",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4552",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:c5b6f18c48929664e7a6ec9dc267de2a092d7884d969ba7d49e766f3c55af1b9",
 "path": "/jp/TSE-PRIME/4552",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is JCR Pharmaceuticals Co.,Ltd., listed on the Prime Market under ticker 4552. Its LEI is 353800IMIU9CQ1DGOS14 and its ISIN is not on the record (GLEIF maps no ISIN to this LEI). Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 13 filings in the window 2025-11-06 to 2026-11-06, across 5 filing days, of which 2 are ad hoc, 9 are regulatory filings and 2 are results. The median gap between filing days is 71.0 days. The latest filing is dated 2026-07-29 and is a regulatory filing, 100 days before the record date 2026-11-06. The Prime Market median is 10 filings, a 29.0-day median cadence gap and 70.0 days median latency across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a 49.5-day median cadence gap and 85.0 days median latency across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 有限責任監査法人 トーマツ, with its location not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's own investor-relations page names 9 research houses: SBI SECURITIES Co., Ltd., Jefferies (Japan) Limited, Citigroup Global Markets Japan Inc., Daiwa Securities Co. Ltd., Nomura Securities Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Morgan Stanley, and MUFG Securities Co., Ltd.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found for the issuer.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record began on no recorded date.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/353800IMIU9CQ1DGOS14"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4552"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YF19"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4552"
  }
 ],
 "title": "JCR Pharmaceuticals Co.,Ltd. (4552) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}